Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia

BACKGROUND: The pharmacokinetic basis of magnesium sulphate (MgSO (4)) dosing regimens for eclampsia prophylaxis and treatment is not clearly established. OBJECTIVES: To review available data on clinical pharmacokinetic properties of MgSO (4) when used for women with pre‐eclampsia and/or eclampsia....

Descripción completa

Detalles Bibliográficos
Autores principales: Okusanya, BO, Oladapo, OT, Long, Q, Lumbiganon, P, Carroli, G, Qureshi, Z, Duley, L, Souza, JP, Gülmezoglu, AM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737322/
https://www.ncbi.nlm.nih.gov/pubmed/26599617
http://dx.doi.org/10.1111/1471-0528.13753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737322/
https://www.ncbi.nlm.nih.gov/pubmed/26599617
http://dx.doi.org/10.1111/1471-0528.13753

Ejemplares similares